|
Hi Paris,
My tumor was 6mm by 5mm, IDCIS.
I had the Oncotype DX test done to see what my risk factor was and I also went to see Dr. Pegram for a consultation. He inputted my info into adjuvant.com and came up with a pretty good risk analysis. He said I had a 84% chance of being without recurrance based on my tumor and chemo would reduce that risk by 25% giving me a 5% added benefit. This put me into the 88% of nonrecurrance.
Then according to Becky, herceptin adds another 50% benefit which would make me another 6% benefit, putting me at 94% chance of not developing another recurrance.
But my situation may be not quite so easily predicted since I am BRCA2. THere are not many studies done on such small tumors let alone those that are BRCA positive.
__________________
*** MARYANNE *** aka HARRIECANARIE
1993: right side DCIS, lumpectomy, rads
1999: left side DCIS, lumpectomy, rads, tamoxifen
2006:
BRCA 2 positive
Stage I, invasive DCIS (6mm x 5mm)
Grade: intermediate
sentinal node biopsy: neg
HER2/neu amplified 4.7
ER+/PR+
TOPO II neg
Oncotype dx 20
Bilat mastectomy with DIEP flap reconstruction
oophorectomy
2007:
6 cycles TCH (taxotere, carboplatin, herceptin)
finished 1 yr herceptin 05/07
Arimidex, stopped after almost 1 yr
Femara
|
Threaded Mode